您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Pyripyropene A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Pyripyropene A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Pyripyropene A图片
CAS NO:147444-03-9
包装与价格:
包装价格(元)
250μg电议
1mg电议

产品介绍
Pyripyropene A 是一种有效的选择性甾醇 O-酰基转移酶 2 (SOAT2)/酰基辅酶 A:胆固醇酰基转移酶 2 (ACAT2) 抑制剂,IC50 为 0.07 μM。
Cas No.147444-03-9
别名啶南平A
化学名3,6-bis(acetyloxy)-4-[(acetyloxy)methyl]-1,3S,4R,4aR,5,6S,6aS,12R,12aS,12bS-decahydro-12-hydroxy-4,6a,12b-trimethyl-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-11-one
Canonical SMILESO=C1OC(C2=CN=CC=C2)=CC3=C1[C@H](O)[C@@]4([H])[C@@](O3)(C)[C@@H](OC(C)=O)C[C@@]5([H])[C@@](COC(C)=O)(C)[C@@H](OC(C)=O)CC[C@@]54C
分子式C31H37NO10
分子量583.6
溶解度DMSO: Soluble,Methanol: Soluble
储存条件Store at -20°C, protect from light, stored under nitrogen
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述 Acyl-CoA: cholesterol acyltransferase (ACAT) is a key enzyme for cholesteryl ester accumulation in atherogenesis, lipoprotein formation in liver, and cholesterol absorption from intestines, all of which are events that contribute to the atherosclerotic process. Two ACAT isozymes have been identified and are expressed in distinct tissues. ACAT1 is ubiquitously expressed at a high level in sebaceous glands, steroidogenic tissues, and macrophages, whereas ACAT2 is expressed predominantly in the liver and intestine. Pyripyropene A, naturally produced by A. fumigates, is a potent inhibitor of ACAT2 with an IC50 value of 70 nM in an in vitro activity assay. It demonstrates high selectivity for the ACAT2 isozyme, inhibiting ACAT1 in a similar assay with an IC50 value of >80 μM.A dose of 10 to 100 mg/kg PPPA inhibits cholesterol absorption in mouse intestine by 30.5-55%. Oral administration to apolipoprotein E-knockout mice at 10-50 mg/kg per day for 12 weeks can lower the levels of plasma cholesterol and hepatic cholesterol, very-low-density lipoprotein, and LDL content, resulting in protection from atherosclerosis development.